Get Affordable Synjardy® (Empagliflozin + Metformin) Globally for Type 2 Diabetes

Summary - Synjardy® (empagliflozin + metformin) is a proven combination medicine for type 2 diabetes. But in the US it costs around $350 monthly with no generic available. MedsPartner provides quality-assured generic empagliflozin metformin at ~75% savings for patients worldwide. This blog shares ways to source affordable empagliflozin metformin combination therapy.

Type 2 diabetes affects millions globally and requires consistent meds to prevent serious complications - like kidney damage, blindness, and heart disease. Blood sugar control is essential for long-term health.

Synjardy® combines two proven diabetes medicines - empagliflozin (Jardiance®) and metformin. Empagliflozin removes excess glucose through urine while metformin reduces glucose production in the liver. Together, they work better than either drug alone. The FDA approved Synjardy® in August 2015 for adults with type 2 diabetes.

The problem? Synjardy® costs around $350 monthly in the US with no generic version available domestically. Many patients struggle to afford continuous treatment, leading to poor blood sugar control and complications. MedsPartner helps patients in 45+ countries - including USA, UK, Australia, New Zealand - access affordable empagliflozin metformin through compliant personal imports.

How does Synjardy® work to control blood sugar in type 2 diabetes?

Synjardy® contains empagliflozin and metformin - two medicines with complementary mechanisms.

Empagliflozin is an SGLT2 inhibitor. It blocks glucose reabsorption in the kidneys - forcing the body to excrete excess sugar through urine instead of returning it to the bloodstream. This lowers blood glucose levels independent of insulin. As a bonus, it also promotes modest weight loss and reduces blood pressure.

Metformin is a biguanide that works through multiple pathways. It decreases glucose production by the liver, reduces glucose absorption in the intestines, and improves the body's sensitivity to insulin. Metformin has been the first-line diabetes med for decades due to its effectiveness and safety profile.

Together in Synjardy®, these meds attack high blood sugar from different angles. Clinical trials showed the combination reduced HbA1c more than metformin alone. Patients also lost notable body weight on average.

Synjardy® vs. Jardiance® + Metformin taken separately?

Some patients wonder if taking Jardiance® (empagliflozin) and metformin as separate pills is different than the Synjardy® combination tablet.

The active ingredients are identical. Synjardy® contains the same empagliflozin and metformin you'd get from individual tablets. Bioequivalence studies confirmed that Synjardy® delivers the same blood levels as taking the components separately.

The main advantage of Synjardy® is convenience. Taking one combination pill twice daily is simpler than managing two separate medicines.

Cost can vary. Sometimes insurance covers the combination differently than individual components. Generic metformin is cheap, but Jardiance® remains expensive. If you're already taking both separately and they're affordable, there's no medical reason to switch to Synjardy®. But if you're starting both meds, Synjardy® offers simpler dosing.

One consideration - Synjardy®'s fixed combinations limit dosing flexibility. If you need different dose adjustments for each component, separate pills give your doctor more options.

Recent updates on Synjardy® and diabetes treatment

Expanded cardiovascular benefits

Empagliflozin has demonstrated significant cardiovascular benefits beyond glucose control. While Synjardy® itself hasn't been studied for these outcomes, the empagliflozin component provides these benefits.

Generic empagliflozin metformin available internationally

While no US generic Synjardy® exists, manufacturers in India and other countries produce bioequivalent generic versions approved by their regulators. These offer the same therapeutic effects at substantially lower costs.

Pediatric approval

Synjardy® was approved in 2023 for children aged 10 and older with type 2 diabetes - addressing a growing need as childhood type 2 diabetes increases.

Why do Synjardy® prices stay high without generic competition?

The original drugmaker invested in costly clinical trials proving the combination's effectiveness and safety - justifying higher costs. FDA approval in 2015 granted market exclusivity periods.

Even though metformin is generic and cheap, the empagliflozin component remains under patent protection in the US. This prevents domestic generic manufacturers from producing Synjardy® combinations. The specialty pharmacy distribution system for diabetes meds adds further costs.

Insurance coverage varies. Even with coverage - copays for brand-name diabetes meds often reach hundreds of dollars monthly.

FDA/EMA-certified manufacturers in India produce quality-assured generics using the same active ingredients. These offer relief to patients across the globe seeking affordable options - through a compliant process of personal importation, supported by MedsPartner.

How much can I save purchasing generic empagliflozin + metformin from MedsPartner?

Standard dosing for Synjardy® is twice daily with meals. A typical prescription is 60 tablets monthly.

At this dosing - branded Synjardy® costs $350 monthly in the US. MedsPartner's generic costs $88 monthly.

You save $262 monthly - that's 75% cost reduction or $3,144 yearly. Over five years of continuous diabetes treatment, savings reach $15,720. For patients needing lifelong therapy, these savings compound significantly.

Is personal import of Synjardy® legal for diabetes patients?

Many countries allow patients to import prescription meds in limited quantities for chronic conditions like diabetes when local options are cost-prohibitive. The rules vary by jurisdiction but typically require a valid prescription from your doctor, declaration of personal use, and purchase quantities limited to 1-3 months.

MedsPartner has managed compliant international shipments for over 9 years, delivering to patients in more than 45 countries. We handle required paperwork for each destination - whether USA, UK, Australia, New Zealand, or developing nations. Our track record includes 30,000+ successful deliveries for chronic disease medicines. Our process starts by helping you understand personal import rules in your country, then processing your order in full compliance with local regulations.

How a patient in Nigeria got affordable empagliflozin metformin through MedsPartner

Maria was diagnosed with type 2 diabetes five years ago. Initially controlled on metformin alone, her HbA1c gradually increased. Her doctor recommended adding empagliflozin - but the cost of branded Jardiance® was prohibitive.

She considered the Synjardy® combination for convenience but local pricing made continuous treatment unsustainable. The monthly cost would consume a significant portion of the family budget.

Working with her doctor, Maria obtained documentation for personal importation. She connected with MedsPartner and arranged access to quality-assured generic empagliflozin metformin.

The cost difference was substantial and made consistent treatment affordable without sacrificing other family needs.

Your questions about Synjardy® price and access answered

Q1. What is the empagliflozin metformin combination brand name? Is there a generic?

A - Synjardy® is the brand name for the empagliflozin + metformin combination. Currently, no generic Synjardy® is available in the US market. But generic versions exist in other countries like India, manufactured to similar quality standards and approved by national regulators.

Q2. Does Medicare or insurance cover Synjardy®?

A - Medicare Part D typically covers Synjardy®, but it's usually placed on higher specialty tiers meaning significant out-of-pocket costs. Most commercial insurance plans cover it but often require prior authorization and may mandate trying metformin alone first (step therapy). Even with coverage, copays frequently range from $50-$300+ monthly depending on your specific plan and deductible status.

Q3. What if my insurance denies Synjardy® coverage or copay is too high?

A - Start by asking your doctor to file an appeal with medical justification. Manufacturer savings programs exist - Boehringer Ingelheim offers a Synjardy® savings card for eligible commercially-insured patients that may reduce copays. Patient assistance programs provide free medicines for qualifying low-income patients. When these options don't work, many diabetes patients access quality-assured generic empagliflozin metformin through compliant personal importation via MedsPartner at ~75% savings.

Q4. How can I trust MedsPartner's generic empagliflozin metformin quality?

A - MedsPartner sources empagliflozin metformin exclusively from manufacturers certified by FDA/EMA. These generics undergo bioequivalence testing proving they deliver the same active ingredients with similar therapeutic effects as branded meds. We provide manufacturer details and expiry dates with every order plus end-to-end shipment tracking. We have supported 30,000+ successful deliveries across 45+ countries over 9 years, backed by verified patient reviews and a 4.5-star Trustpilot rating.

Q5. How do I order affordable Synjardy® generic from MedsPartner?

A - Visit MedsPartner's empagliflozin metformin product page and upload your prescription without payment. Our team verifies prescription validity and checks your country's importation regulations. We then provide final pricing including shipping costs. After you confirm and pay, we handle all customs documentation and ship via international carriers following your local rules.

Q6. I'm a doctor - how can I help my patient get affordable Synjardy®?

A - Email support@medspartner.com with patient information and prescription. We work directly with patients and families to arrange compliant personal importation to their doorstep per local laws. We provide affordable medicine access that makes your prescribed treatment plan financially sustainable for patients facing cost barriers.

Q7. What are the side effects of Synjardy®?

A - Common side effects of Synjardy from empagliflozin include urinary tract infections and yeast infections (especially in women). Metformin commonly causes diarrhea, nausea, and stomach upset - usually temporary and lessened by taking it with food. Serious but rare risks include lactic acidosis, dehydration and low blood pressure, and diabetic ketoacidosis. Always take Synjardy® with meals and stay well-hydrated.

Q8. What savings can I expect switching to MedsPartner's generic Synjardy®?

A - At standard twice-daily dosing (60 tablets monthly), branded Synjardy® costs $350 in the US. MedsPartner's generic costs $88 monthly. That's $262 monthly savings or $3,144 yearly - a 75% cost reduction. These savings make consistent treatment possible without financial hardship.

Affordable diabetes meds delivered to your doorstep

Type 2 diabetes requires lifelong management. Synjardy® offers effective blood sugar control that can prevent serious complications. But it only works if you can afford to take your medicine consistently. Skipping doses due to cost leads to poor control, complications, and ultimately higher healthcare costs. That’s the problem MedsPartner solves with affordable generic empagliflozin + metformin combination.

Looking for affordable Synjardy® variants? Contact us at support@medspartner.com or start your order on our website. We're here to help you access the diabetes medications you need at prices you can sustain.

About the Author - Atul Goyal leads strategic operations at MedsPartner - focusing on global medicine access for underserved patient populations. His expertise spans international pharmaceutical logistics, regulatory compliance & patient advocacy - gained through direct work coordinating medicine deliveries across diverse healthcare systems. At MedsPartner, he develops partnerships with certified manufacturers and healthcare providers worldwide - ensuring patients receive quality-assured treatments regardless of geographic or economic barriers.